Compare POLY MEDICURE with MANOJ SURGIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

POLY MEDICURE vs RAAJ MEDISAFE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    POLY MEDICURE RAAJ MEDISAFE POLY MEDICURE/
RAAJ MEDISAFE
 
P/E (TTM) x 59.5 13.0 459.0% View Chart
P/BV x 9.0 36.8 24.5% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 POLY MEDICURE   RAAJ MEDISAFE
EQUITY SHARE DATA
    POLY MEDICURE
Mar-21
RAAJ MEDISAFE
Mar-21
POLY MEDICURE/
RAAJ MEDISAFE
5-Yr Chart
Click to enlarge
High Rs91314 6,611.2%   
Low Rs2079 2,302.2%   
Sales per share (Unadj.) Rs82.029.1 282.1%  
Earnings per share (Unadj.) Rs13.82.1 657.9%  
Cash flow per share (Unadj.) Rs18.82.8 682.7%  
Dividends per share (Unadj.) Rs2.500-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs100.61.0 10,268.9%  
Shares outstanding (eoy) m95.8810.94 876.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.80.4 1,741.0%   
Avg P/E ratio x40.55.4 746.8%  
P/CF ratio (eoy) x29.84.1 719.7%  
Price / Book Value ratio x5.611.6 47.8%  
Dividend payout %18.10-   
Avg Mkt Cap Rs m53,703125 43,050.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,41824 5,805.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m7,865318 2,472.8%  
Other income Rs m1840 87,690.5%   
Total revenues Rs m8,049318 2,529.0%   
Gross profit Rs m2,16541 5,340.2%  
Depreciation Rs m4757 6,683.8%   
Interest Rs m1067 1,430.2%   
Profit before tax Rs m1,76726 6,748.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4423 13,849.5%   
Profit after tax Rs m1,32623 5,766.2%  
Gross profit margin %27.512.7 216.0%  
Effective tax rate %25.012.2 205.0%   
Net profit margin %16.97.2 233.1%  
BALANCE SHEET DATA
Current assets Rs m7,49573 10,233.3%   
Current liabilities Rs m2,15165 3,295.6%   
Net working cap to sales %67.92.5 2,709.8%  
Current ratio x3.51.1 310.5%  
Inventory Days Days1955 3,956.9%  
Debtors Days Days72656,265 1.3%  
Net fixed assets Rs m5,17993 5,575.9%   
Share capital Rs m479109 439.7%   
"Free" reserves Rs m9,168-98 -9,327.0%   
Net worth Rs m9,64811 89,998.5%   
Long term debt Rs m63385 743.8%   
Total assets Rs m12,674166 7,629.2%  
Interest coverage x17.64.5 389.6%   
Debt to equity ratio x0.17.9 0.8%  
Sales to assets ratio x0.61.9 32.4%   
Return on assets %11.318.3 61.7%  
Return on equity %13.7214.5 6.4%  
Return on capital %18.235.1 51.9%  
Exports to sales %61.30-   
Imports to sales %26.90-   
Exports (fob) Rs m4,818NA-   
Imports (cif) Rs m2,116NA-   
Fx inflow Rs m4,8180-   
Fx outflow Rs m2,1160-   
Net fx Rs m2,7020-   
CASH FLOW
From Operations Rs m1,18722 5,326.7%  
From Investments Rs m-4,356-28 15,668.5%  
From Financial Activity Rs m3,1695 61,783.4%  
Net Cashflow Rs m10 -255.3%  

Share Holding

Indian Promoters % 44.5 73.5 60.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 17.1 0.0 -  
FIIs % 14.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 55.2 26.6 208.1%  
Shareholders   35,166 8,664 405.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster



Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

POLY MEDICURE 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of POLY MEDICURE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of POLY MEDICURE. Also includes updates on the valuation of POLY MEDICURE.

POLY MEDICURE Announces Quarterly Results (1QFY22); Net Profit Up 42.0% (Quarterly Result Update)

Jul 31, 2021 | Updated on Jul 31, 2021

For the quarter ended June 2021, POLY MEDICURE has posted a net profit of Rs 369 m (up 42.0% YoY). Sales on the other hand came in at Rs 2 bn (up 24.4% YoY). Read on for a complete analysis of POLY MEDICURE's quarterly results.

ITC to Coal India: Are these the Best Dividend Stocks You can Count on? (Views On News)

Jan 25, 2022

A list of companies that have paid dividends regularly for years, creating value for shareholders.

JLR, Corus, Tetley - Was Ratan Tata's Go Global Strategy Right Afterall? (Views On News)

Jan 20, 2022

Ratan Tata took the lead in global acquisitions and changed the mindset of India's business leaders. Was he successful after all?

Top 4 Oxygen Stocks to Add to Your Watchlist (Views On News)

Jan 12, 2022

Amid a surge in Covid cases, states have been asked to keep adequate stock of medical oxygen for at least 48 hours.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

POLY MEDICURE SHARE PRICE


Jan 28, 2022 (Close)

TRACK POLY MEDICURE

  • Track your investment in POLY MEDICURE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

POLY MEDICURE - SHREE PACETRONIX COMPARISON

COMPARE POLY MEDICURE WITH

MARKET STATS